Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonya Marshall-Gradisnik

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Science (New York, N.Y.)|September 8, 2022
Understanding myalgic encephalomyelitisSonya Marshall-Gradisnik, Natalie Eaton-Fitch
Journal of Translational Medicine|July 14, 2026
Australian registry reports poor health and wellbeing in people living with ME/CFSNatalie Eaton-Fitch, Sonya Marshall-Gradisnik
Journal of Translational Medicine|April 22, 2016
ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patientsTeilah Kathryn Huth, Donald Staines, Sonya Marshall-Gradisnik
Journal of Translational Medicine|December 5, 2019
Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patientsCassandra Balinas, Helene Cabanas, Donald Staines, et al.
BMC Medical Genetics|November 13, 2016
A targeted genome association study examining transient receptor potential ion channels, acetylcholine receptors, and adrenergic receptors in Chronic Fatigue Syndrome/Myalgic EncephalomyelitisSamantha Johnston, Donald Staines, Anne Klein, et al.
Brain, Behavior, & Immunity - Health|June 17, 2026
Investigation of BOLD signal intensities in long COVID patients using 7T functional MRIMaira Inderyas, Kiran Thapaliya, Sonya Marshall-Gradisnik, et al.
Neuropsychiatric Disease and Treatment|June 27, 2009
Postulated vasoactive neuropeptide immunopathology affecting the blood-brain/blood-spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?Donald R Staines, Ekua W Brenu, Sonya Marshall-Gradisnik
BMC Immunology|May 12, 2019
Identification and characterisation of transient receptor potential melastatin 2 and CD38 channels on natural killer cells using the novel application of flow cytometryCassandra Balinas, Helene Cabanas, Donald Staines, et al.
The European Journal of Neuroscience|August 6, 2021
Diffusion tensor imaging reveals neuronal microstructural changes in myalgic encephalomyelitis/chronic fatigue syndromeKiran Thapaliya, Sonya Marshall-Gradisnik, Donald Staines, et al.
Brain, Behavior, & Immunity - Health|December 17, 2025
Altered brain tissue microstructure and neurochemical profiles in long COVID and recovered COVID-19 individuals: A multimodal MRI studyKiran Thapaliya, Sonya Marshall-Gradisnik, Maira Inderyas, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Science (New York, N.Y.)|September 8, 2022
Understanding myalgic encephalomyelitisSonya Marshall-Gradisnik, Natalie Eaton-Fitch
Journal of Translational Medicine|July 14, 2026
Australian registry reports poor health and wellbeing in people living with ME/CFSNatalie Eaton-Fitch, Sonya Marshall-Gradisnik
Journal of Translational Medicine|April 22, 2016
ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patientsTeilah Kathryn Huth, Donald Staines, Sonya Marshall-Gradisnik
Journal of Translational Medicine|December 5, 2019
Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patientsCassandra Balinas, Helene Cabanas, Donald Staines, et al.
BMC Medical Genetics|November 13, 2016
A targeted genome association study examining transient receptor potential ion channels, acetylcholine receptors, and adrenergic receptors in Chronic Fatigue Syndrome/Myalgic EncephalomyelitisSamantha Johnston, Donald Staines, Anne Klein, et al.
Brain, Behavior, & Immunity - Health|June 17, 2026
Investigation of BOLD signal intensities in long COVID patients using 7T functional MRIMaira Inderyas, Kiran Thapaliya, Sonya Marshall-Gradisnik, et al.
Neuropsychiatric Disease and Treatment|June 27, 2009
Postulated vasoactive neuropeptide immunopathology affecting the blood-brain/blood-spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?Donald R Staines, Ekua W Brenu, Sonya Marshall-Gradisnik
BMC Immunology|May 12, 2019
Identification and characterisation of transient receptor potential melastatin 2 and CD38 channels on natural killer cells using the novel application of flow cytometryCassandra Balinas, Helene Cabanas, Donald Staines, et al.
The European Journal of Neuroscience|August 6, 2021
Diffusion tensor imaging reveals neuronal microstructural changes in myalgic encephalomyelitis/chronic fatigue syndromeKiran Thapaliya, Sonya Marshall-Gradisnik, Donald Staines, et al.
Brain, Behavior, & Immunity - Health|December 17, 2025
Altered brain tissue microstructure and neurochemical profiles in long COVID and recovered COVID-19 individuals: A multimodal MRI studyKiran Thapaliya, Sonya Marshall-Gradisnik, Maira Inderyas, et al.
Pageof 9